Durable remissions in two adult patients with Burkitt lymphoma following anti-CD19 CAR T-cell therapy: a single center experience-Reference-Cited by-同舟云学术

Durable remissions in two adult patients with Burkitt lymphoma following anti-CD19 CAR T-cell therapy: a single center experience

Published:2022-06-09 Issue:10 Volume:63 Page:2469-2473
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Seitter Samantha J.¹,McClelland Paul H.¹^ORCID,Ahlman Mark A.²,Goff Stephanie L.¹,Yang James C.¹,McIntyre Lori¹,Rosenberg Steven A.¹,Kochenderfer James N.¹,Brudno Jennifer N.¹

Affiliation:

1. Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

2. Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD, USA

Funder

National Cancer Institute

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2076853

Reference17 articles.

1. 2016 US lymphoid malignancy statistics by World Health Organization subtypes

2. The treatment of Burkitt lymphoma in adults

3. Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma

4. Approach to the Diagnosis and Treatment of Adult Burkitt's Lymphoma

5. CAR T cells induce a complete response in refractory Burkitt Lymphoma

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing Burkitt Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Optimization of anti-CD19 CAR T cell production for treatment of patients with chronic lymphocytic leukemia;Molecular Therapy - Methods & Clinical Development;2024-03

3. Broadening the horizon: potential applications of CAR-T cells beyond current indications;Frontiers in Immunology;2023-11-27

4. CAR-T Cell Therapy in the Treatment of Pediatric Non-Hodgkin Lymphoma;Journal of Personalized Medicine;2023-11-10

5. Bone Marrow Aplasia after CAR-T-Cell Therapy for Relapsed/Refractory Burkitt’s Lymphoma;Medical Sciences;2023-10-12